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ColocalizationCrimean Congo hemorrhagic fever virus (CCHFV) is a human pathogen that causes a severe disease with high
fatality rate for which there is currently no speciﬁc treatment. Knowledge regarding its replication cycle is
also highly limited. In this study we developed an in situ technique for studying the different stages during
the replication of CCHFV. By integrating reverse transcription, padlock probes, and rolling circle ampliﬁcation,
wewere able to detect and differentiate between viral RNA (vRNA) and complementary RNA (cRNA)molecules,
and to detect viral protein within the same cell. These data demonstrate that CCHFV nucleocapsid protein (NP)
is detectable already at 6 hours post infection in vRNA- and cRNA-positive cells. Confocal microscopy showed
that cRNA is enriched and co-localized to a large extent with NP in the perinuclear area, while vRNA has a
more random distribution in the cytoplasm with only some co-localize with NP. However, vRNA and cRNA did
not appear to co-localize directly.
© 2012 Elsevier Inc. All rights reserved.Introduction
Crimean Congo hemorrhagic fever virus (CCHFV) belongs to the
genus Nairovirus in the family Bunyaviridae. It is a human pathogen
that causes severe disease with high fatality rate (3–30%) and is clas-
siﬁed as a BSL-4 pathogen (Ergonul, 2006). Due to limited research
facilities and, until recently, a lack of animal models (Bente et al.,
2010; Bereczky et al., 2010), detailed investigation of the biology of
CCHFV has been difﬁcult. The CCHFV genome is tri-segmented, with
the small (S) segment coding for the nucleocapsid protein (NP), the
medium (M) segment for the two glycoproteins (Gn and Gc), and
the large (L) segment for the viral polymerase. General replication
by members of the Bunyaviridae involves entry by endocytosis, fusion
of the viral membrane with endosome membrane, primary transcrip-
tion, translation of viral proteins, and replication of viral (v) RNA via
a complementary (c) RNA intermediate in the cytoplasm. This is
followed by assembly of the virions close to Golgi (Whitehouse,
2004). We have previously shown CCHFV to enter by clathrin-
dependent endocytosis in a pH-dependent manner (Simon et al.,
2009b). We have also demonstrated the role of the cytoskeleton for
the replication process (Andersson et al., 2004; Simon et al., 2009a).nicable Disease Control, SE-171
ki.se (A. Mirazimi).
rights reserved.However, the replication and translation of the CCHFV genome still
remain largely uninvestigated.
The padlock probe is a linear oligonucleotide probe that is
designed to hybridize to its target sequence head-to-tail, and then
become circularized through the action of DNA ligase in a strictly
target sequence-dependent reaction (Nilsson et al., 1994). Circular-
ized padlock probes are ampliﬁed by Rolling Circle Ampliﬁcation
(RCA) (Fire and Xu, 1995) to generate long replication products that
can be individually detected (Lizardi et al., 1998). By using the target
sequence to prime the RCA, robust detection of single DNA molecules
in situ has been achieved, providing information about the localization
at single-cell level. This approach was ﬁrst used to genotype a point
mutation in mitochondrial DNA (Larsson et al., 2004), and has later
been used for detection of bacterial DNA sequences in situ (Wamsley
and Barbet, 2008) and viral DNA (Henriksson et al., 2011). It has also
been used for the detection of isolated RNA in solution for positive
(Wang et al., 2005) and negative stranded (Baner et al., 2007; Gyarmati
et al., 2008; Ke et al., 2011) RNA viruses, but in situ detection of RNA
viruses has not yet been reported.We recently developed an in situ pad-
lock probe technique for efﬁcient detection of single RNA sequences by
applying locked nucleic acid (LNA) primers to ﬁrst convert target
mRNAs into localized cDNA molecules, which are then detected with
padlock probes and target-primed RCA (Larsson et al., 2010).
In this study, we have developed a technique that enables detection
of the viral genome in cell culture through the use of a padlock-probe
and rolling circle ampliﬁcation (RCA)-based protocol for the detection
88 C. Andersson et al. / Virology 426 (2012) 87–92of vRNA and/or cRNA of CCHFV, combined with immunoﬂuorescence-
based NP staining.
Results and discussion
As shown in Fig. 1c, we were able to detect rolling circle products
(RCPs) for vRNA in infected cells. When reverse transcription or T4 li-
gase enzyme was omitted from their respective step, no signal from
the padlock probe was observed (Figs. 1e–f), verifying that cDNA syn-
thesis and padlock probe ligation are essential. Some self-priming
could be detected when primer was omitted from the RT-step
(Fig. 1d), but the number of signals was very low and the intensity
was also signiﬁcantly lower than for analysis with primer. Self-
priming during RT has previously been reported for Hantaviruses
and Dengue viruses (Tuiskunen et al., 2010).
In order to investigate the kinetics of vRNA during the replication
process, we studied the number of vRNA signals over time post-
infection. We found that NP was already detectable at 6 hpi in vRNA-
positive cells, indicating a very fast replication process for CCHFV
(data not shown). We also could ﬁnd vRNA signals in NP negative
cells. However, the background level of detected signals by Blobﬁnder
in the mock infected cells was too high to make any conclusion for the
signals at 6 hpi (Fig. 2B). As shown in Fig. 2C, we could demonstrate
that NP-positive cells had a higher number of RCPs per cell than NP-
negative cells, suggesting that replication in vRNA-positive and NP-
negative cellsmost probably is in a very early stage of infection. Further-
more, we found an increased number of vRNA-positive cells at 24 hpi
compared with 6 hpi (Fig. 2B). The confocal analysis of vRNA and NP
demonstrated that there was some co-localization, which was limited
to areas where CCHFV NP assembled or aggregated (Fig. 2A).
We proceeded to investigate whether CCHFV cRNA could be
detected by using the same experimental set-up. As shown in
Fig. 3B, we were able to detect cRNA signals already at 6 hpi, suggest-
ing that active replication had been initiated. The number of cRNA
positive cells also increased when comparing the 6 hpi and 24 hpi
results (Fig. 3B). The confocal analysis revealed that in contrast to
vRNA, cRNA signals are greatly enriched in the NP containing parts
of the cytoplasm and co-localize with the NP aggregates.
In order to determine whether CCHFV vRNA and cRNA could be
detected simultaneously in the same infected cell, we also carried
out experiments using both sets of speciﬁc primers and probes in
the same steps, using differently ﬂuorescently labeled visualizationFig. 1. In situ detection of CCHFV vRNA using padlock probes and targeted-primed RCA in Ve
in green, NP antibody in red, and nuclei in blue of (b) mock infected and (c) infected cells, a
primers (self-priming) or (e) without reverse transcriptase, and (f) with T4 ligase omittedprobes (Table 1). The detection of both transcripts is possible, as the
preference for perfectly matched padlock probes at the circularization
step would enable distinction between the two targets (Larsson et
al., 2010). As shown in Fig. 4A, we were able to detect both vRNA
and cRNA signals within the same cell. We found that 3% (6 hpi) of
the cells were positive only for vRNA (Fig. 4B), most probably because
they were in an immediate early stage of infection. We also found
that 17% (6 hpi) were positive only for cRNA (Fig. 4B), most likely
due to higher background in the cRNA staining. Visual inspection
clearly demonstrated that these digitally detected background sig-
nals, as counted by Blobﬁnder, in the cRNA channel have a different
spectral proﬁle than the correct signals, which we have not taken
into account for in the software. With some development of the Blob-
ﬁnder software such background signals can be removed. Another
factor that needs to be taken account for when interpreting our data
is that we have not determined the exact detection efﬁciency in our
experiments. It has previously been estimated based on PCR compar-
isons that the overall in situ detection efﬁciency for this technique
could be around 30% of available mRNA transcripts (Larsson et al.,
2010). The number of signals that we record does therefore not di-
rectly translate to number of RNA molecules in the cells. This could
explain why we detected cells containing cRNA signal but lacking
detectable vRNA signal, as the technique might have failed to detect
the small number of vRNA expected to be present in these cells dur-
ing early replication. However, it is likely that the detection efﬁciency
is highly reproducible between experiments and that the relative
levels of cRNA and vRNA can be determined with high conﬁdence.
A general comparison of the number of RCPs per cell clearly shows
that more cRNA signals than vRNA were detected, both when analyzed
separately (Figs. 2C and 3C), and when detected together (Figs. 4C and
D). Real-time PCR analysis of CCHFV RNA expression also conﬁrms a
higher level of cRNA transcripts compared to vRNA (Fig. 4E). This
could be due to the presence of more cRNA transcripts during infection,
or vRNA being less accessible for the primer, possibly due to interaction
with NP. In studies on other members of the Bunyaviridae family, NP
has been shown to preferentially bind to vRNA compared with cRNA
(Mir et al., 2010), but whether this explains the lower levels of vRNA
observed here remains to be investigated.
The number of RCPs for both the transcripts was lower when ana-
lyses were performed simultaneously (Figs. 4C and D) compared with
separate analyses (Figs. 2C and 3C). This is in line with observations
made by Larsson et al., that multiplex analysis has a slightly lowerro cells. (a) Schematic representation of the procedure. Visualization with vRNA shown
s well as infected cells where the reverse transcriptase step was performed (d) without
from the ligase step.
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Fig. 2. In situ detection and number of signals of CCHFV vRNA in situ at 6 and 24 hpi using padlock probes and targeted-primed RCA in Vero cells. (A) Representative picture of
confocal analysis of infected cells 24 hpi with nuclei in blue, NP in red, vRNA in green and co-localization of NP and vRNA in white. (B) Percentage of signal-positive cells and
(C) number of signals per cell as digitally detected by Blobﬁnder. Relative levels (mean±sd) from 10 pictures are illustrated. Signiﬁcance is indicated by ** (Pb0.01, statistics
were done using Student's t-test).
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probes and/or cDNA primers (Larsson et al., 2010).
In order to further assess the location of the genome, we performed
confocal microscopy analysis and found vRNA mainly scattered
throughout the cytoplasm, while cRNA was more concentrated inmock infected CCHFV infected
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Fig. 3. In situ detection and number of signals of CCHFV cRNA 6 and 24 hpi with padlock probe
infected cells 24 hpi with nuclei in blue, NP in red, cRNA in green and co-localization of NP and
digitally detected by Blobﬁnder. Relative levels (mean±sd) from 10 pictures are illustrated. Sspeciﬁc areas in the cells, co-localizing with NP. We also found some
co-localization of vRNA and cRNA (Fig. 4A). As shown in Figs. 2 and 3,
we had already demonstrated co-localization of vRNA or cRNA with
NP in these speciﬁc areas. The reason for this distribution of transcripts
remains to be investigated.CCHFV infected 6hpi
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s and targeted-primed RCA in Vero cells. (A) Representative picture of confocal analysis of
cRNA inwhite. (B) Percentage of signal-positive cells and (C) number of signals per cell as
igniﬁcance is indicated by ** (Pb0.01, statistics were done using Student's t-test).
Table 1
CCHFV primers, padlock and detection probes.
vRNA primera 5′-a+ag+ga+aa+gg+ga+at+atttgatgaagc-3′
vRNA padlock probe 5′-ttaagaaggtttgttatcatgactaccgagatgtaccg
ctatcgtatatcgtgtcacaggtcgtttcttccctgggcctt
ggcaatatgc-3′
vRNA visualization probe 1 5′-FITC-ccgagatgtaccgctatcgt-3′
cRNA primera 5′-t+ag+aa+tc+ag+gt+tc+cttctcctaatc-3′
cRNA padlock probe 5′-ataggtttccgtgtcaatgctctatcctcaatgctgctgct
gctgtactactagatcagttggactcgatgcctggaagtgga
gaaaagac-3′
cRNA visualization probe 1 5′ FITC -cctcaatgctgctgctgtactac-3′
cRNA visualization probe 2 5′ Texas Red -cctcaatgctgctgctgtactac-3′
a n+=LNA.
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reverse transcription, padlock probes, and target-primed RCA can be
combined and used to study the replication cycle of negative-
stranded RNA viruses in situ. The results also show that this technique
is capable of distinguishing between vRNA and cRNA strands.
By detecting and distinguishing two opposite strands, vRNA and
cRNA, combined with protein staining in ﬁxed cells, this technique
could prove a useful tool when studying different stages and locations
of viral replication in the natural setting. Since the technique is per-
formed at single cell level, it gives a more precise view of the replica-
tion procedure than conventional PCR techniques, which only give an
overall result and where cell–cell differences are not as visual. As
expected and as previously reported (Bengtsson et al., 2005; Levsky
and Singer, 2003), we detected different transcript levels in different
cells. This is most likely because cells in the same well are in different
cell phases or have small time differences between when they be-
came infected. Such small differences would not be apparent unless
a single cell analysis technique is used. We believe that the technique
we have developed will enable more exact and detailed studies of
virus–cell interactions.
Material and methods
Virus infection
Vero cells were cultured, seeded on chamber slides, and infected
as previously described (Simon et al., 2009a) with CCHFV strain
IbAr 10200 (Flick et al., 2003) at a moi of 5. At 6 and 24 hours post
infection (hpi), the cells were ﬁxed in 3% (w/v) paraformaldehyde
in PBS at room temperature for 20 min or added 200 μl of TRIzol
and placed in −70 until further analysis. All handling of the virus
was carried out at the BSL4 facility at the Swedish Institute for Infec-
tious Disease Control, Solna, Sweden.
RT
One speciﬁc LNA primer towards CCHFV vRNA and one towards
CCHFV cRNA were designed as well as speciﬁc padlock probes towards
each synthesized cDNA (Table 1). The padlock probes was 5′ phosphor-
ylated at a concentration of 2 μM with 0.2 U μl−1 T4 polynucleotide
kinase (Fermentas) in the manufacturer's buffer A, supplemented
with 1 mM ATP for 30 min at 37 °C, followed by inactivation of the
enzyme for 10 min at 65 °C. The RCPswere later visualized using specif-
ic ﬂuorescent detection probes (Table 1).
The ﬁxed slides (CCHFV or Mock Infected) were rinsed twice in
PBS and 0.1 M HCl in DEPC H2O was added for 10 min, followed by
PBS rinsing. A solution containing 0.5 μM cDNA primer, 20 U μl−1
RevertAid M-MuLV reverse transcriptase (Fermentas), 1× the sup-
plied buffer, 500 nM dNTPs (Fermentas), 0.2 μg μl−1 BSA (Fermentas)
and 1 U μl−1 RiboLock RNase Inhibitor (Fermentas) in DEPC H2O was
then added and the slides were incubated for 1 h at roomtemperature followed by 3 h at 37 °C. They were brieﬂy washed
twice in PBS, followed by a post-ﬁxation step in 3% paraformaldehyde
for 10 min at room temperature, and again washed in PBS. The RNA
portion of the RNA–cDNA complex was degraded by adding a solution
containing 0.2 U μl−1 Ribonuclease H (Fermentas), 1× Tango Buffer
(Fermentas) and 0.2 μg μl−1BSA in DEPC H2O and incubating at
37 °C for 25 min under a cover slip. Slides were then washed twice
in washing buffer (0.15 M NaCl, 0.1 M Tris HCl, 0.05% Tween-20 at
pH 7.5 in PBS).
Rolling circle ampliﬁcation (RCA) and visualization
Ligation was carried out by adding 100 nM padlock probe together
with 0.1 U μl−1 T4 DNA ligase (Fermentas), 1× the supplied buffer,
1 mM ATP, 250 mM NaCl and 0.2 μg μl−1 BSA in DEPC H2O to the
slides, incubating at 37 °C for 15 min and then rinsing twice in
DEPC-treated 2xSSC with 0.05% Tween-20 at 37 °C for 5 min, followed
by one wash in washing buffer. To ensure a 3′end close to the padlock
probe binding site, which is required for efﬁcient target-primed RCA,
we applied the site-speciﬁc target-strand cleavage approach described
by Howell et al. (2010). In short, a solution containing 1.5 uM Mut Y
DNA Glycosylase (Trevigen, Nordic Biosite), 0.2 U μl−1 Endonuclease
IV (Fermentas), 20 mM Tris–HCl (pH 7.6), 30 mM NaCl, 1 mM EDTA
and 0.1 M KCl, 1 mM DTT and 0.5 μg μl−1 BSA in DEPC H2O was added
and slides were incubated at room temperature for 30 min under a
cover slip. The slides were washed in washing buffer and dried in
an EtOH series of 70%, 85% and 99.5% EtOH for 3 min each. RCA was
performed with 1 U μl−1 Φ29 DNA polymerase (Fermentas) in 1× the
supplied reaction buffer, 250 μMdNTPs, 0.2 μg μl−1 BSA and 5% glycerol
in DEPC H2O, incubated at 37 °C overnight and followed by a wash in
washing buffer. The RCPs were visualized using 250 nM detection
probe in 2xSSC and 20% formamide at 37 °C for 30 min, washing in
washing buffer and use of an EtOH series as previously described. For
quantiﬁcation, 10 pictures with 13 z-stacks with 0.475 nm between
two z-stacks were taken at magniﬁcation 20× and the number of
RCPs corresponding to every cell nucleus was digitally counted using
Blobﬁnder software (Allalou and Wahlby, 2009) (version 3.0_beta).
Immunostaining
The slides were stained for CCHFV NP as previously described
(Simon et al., 2009a), with visualization using Alexa Fluor 594 goat
anti-mouse antibody (Invitrogen, Carlsbad, CA).
Confocal analysis
For confocal imaging, we used a Bio-Rad Radiance 2100 and Radiance
2000MP (Carl Zeiss, Jena, Germany) to assess dual or triple labeling.
Images were taken in sequence after inserting the signal enhancing
lenses by activating channel 1 (blue); Mai-Tai laser (815 nm), with
dichroic beamsplitter 500DCLPXR, blocking ﬁlter BGG22 and emission
ﬁlter D488/10; channel 2 (green): Argon laser (488 nm), no blocking
ﬁlter and emission ﬁlter HQ515/30; and channel 3 (red): Argon laser
(488 and 514 nm) or Red HeNe laser, no blocking ﬁlter and the emission
ﬁlters HQ590/70 or a HQ660 LP. The microscope was a Nikon Eclipse
TE2000U (Tokyo, Japan), equippedwith PlanApoDicH x60 oil immersion
objective (NA 1.40). The images were analyzed by Image J.
Quantitative real-time PCR
Real-time PCR was performed on samples of infected or mock
infected cells to determine relative RNA expression. The TRIzol sam-
ples were added chloroform and isolated for total RNA using RNeasy
Mini Kit (Qiagen). cDNA synthesis using sense, antisense or random
primers as well as quantitative real-time PCR was performed as pre-
viously described with GAPDH as endogenous control (Simon et al.,
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2, Applied Biosystems) based on the Ct value for each sample and
with the reference Ct set to 1. Mock infected control was always neg-
ative for CCHFV RNA.
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